Max Robotics — Global Service Robot Directory + US Certification

About

James Wright is a pioneering researcher in the field of drug delivery and gastrointestinal physiology, with a focus on enhancing macromolecule bioavailability. His most notable contribution is the development of an in situ forming synthetic epithelial lining, a breakthrough technology that temporarily modifies the intestinal barrier to improve the absorption of large therapeutic molecules, such as proteins and peptides. This work, detailed in his highly cited 2025 paper "Enhanced macromolecule bioavailability in rats and pigs using an in situ forming synthetic epithelial lining," has garnered significant attention for its potential to revolutionize oral drug delivery for biologics, which are typically limited to injection. Wright's research addresses a critical bottleneck in pharmaceutical science, offering a non-invasive alternative that could improve patient compliance and treatment outcomes for chronic diseases. His innovative approach has already demonstrated efficacy in preclinical models, laying the groundwork for future translational studies. With a growing citation count reflecting the impact of his work, Wright is recognized as a rising leader in biomaterials and drug delivery, whose findings promise to reshape how we administer complex therapeutics.